CareDx (CDNA) revenue breakdown
By product, Testing services revenue is the largest at 72% of fiscal 2025 revenue; Patient and digital solutions revenue grew fastest, 84% a year over 9 years.
By region, United States is the largest at 95% of fiscal 2025 revenue; Rest of World grew fastest, 32% a year over 9 years.
Revenue by product
Fiscal years, as CareDx reports them in its 10-K filings; fiscal 2025 total $380M.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Testing services revenue | $30M | $33M | $60M | $105M | $164M | $259M | $264M | $210M | $249M | $274M | 72% |
| Patient and digital solutions revenue | $236,000 | $584,000 | $595,000 | $4M | $9M | $10M | $29M | $37M | $44M | $57M | 15% |
| Product revenue | $11M | $15M | $16M | $18M | $19M | $27M | $29M | $34M | $41M | $48M | 13% |
Revenue by region
Fiscal years, as CareDx reports them in its 10-K filings; fiscal 2025 total $380M.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $33M | $37M | $66M | $116M | $182M | $282M | $308M | $266M | $318M | $360M | 95% |
| Rest of World | $2M | $3M | $3M | $3M | $3M | $5M | $5M | $15M | $16M | $20M | 5% |
| Europe | $6M | $8M | $8M | $8M | $8M | $10M | $10M | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CDNA.
Open CDNA in InvestinglyQuestions
Where does CareDx make its money?
In fiscal 2025, by product: Testing services revenue $274M, Patient and digital solutions revenue $57M, Product revenue $48M.
From CareDx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.